Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Nat Immunol ; 20(12): 1594-1602, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31745337

RESUMEN

IL-17 is a highly versatile pro-inflammatory cytokine crucial for a variety of processes, including host defense, tissue repair, the pathogenesis of inflammatory disease and the progression of cancer. In contrast to its profound impact in vivo, IL-17 exhibits surprisingly moderate activity in cell-culture models, which presents a major knowledge gap about the molecular mechanisms of IL-17 signaling. Emerging studies are revealing a new dimension of complexity in the IL-17 pathway that may help explain its potent and diverse in vivo functions. Discoveries of new mRNA stabilizers and receptor-directed mRNA metabolism have provided insights into the means by which IL-17 cooperates functionally with other stimuli in driving inflammation, whether beneficial or destructive. The integration of IL-17 with growth-receptor signaling in specific cell types offers new understanding of the mitogenic effect of IL-17 on tissue repair and cancer. This Review summarizes new developments in IL-17 signaling and their pathophysiological implications.


Asunto(s)
Enfermedades del Sistema Inmune/inmunología , Inflamación/inmunología , Interleucina-17/metabolismo , Neoplasias/inmunología , Receptores de Interleucina-7/metabolismo , Animales , Células Cultivadas , Humanos , Transducción de Señal
2.
Trends Immunol ; 42(12): 1073-1076, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34728144

RESUMEN

Covalent RNA modifications that regulate gene expression post transcriptionally, in particular N6-methyladenosine (m6A), are emerging as important regulators of autoimmune responses. Here, we highlight new findings describing the functional diversity and specificity of m6A modifications and their regulation in the context of autoimmunity.


Asunto(s)
Autoinmunidad , ARN Mensajero/metabolismo , Humanos , Inflamación
3.
Clin Exp Immunol ; 212(1): 39-51, 2023 04 07.
Artículo en Inglés | MEDLINE | ID: mdl-36759947

RESUMEN

Salivary gland epithelial cells (SGECs) play an active role in primary Sjogren's syndrome (pSS) pathogenesis. Quantitative and qualitative abnormalities of saliva might expose SGECs to chronic hyperosmolarity. We aimed to decipher the links between hyperosmolar stimulation of SGECs and lymphocytic infiltration of the salivary glands (SG) observed in pSS. RNAseq was performed on NS-SV-AC cells stimulated with hyperosmolar media containing NaCl (100 mM) or sucrose (200 mM), or with iso-osmolar (Iso) medium. RNAseq was performed on primary cultured SGECs from pSS and controls, in the presence or not of B cells. Hyperosmolar stimulation of NS-SV-AC-cells identified an upregulation of interferon-induced (MX1, IFIT2) and MMPs genes. Enrichment analysis revealed an over-representation of fibrosis pathway. In parallel, RNAseq of SGECs comparing pSS to controls identified an over-representation of a pathway involving MMPs. Given the unexpected upregulation of collagen (COL3A1, COL1A2) and ADAMTS genes in pSS SGECs, we hypothesized that SGECs might undergo epithelial-mesenchymal transition. ZEB2 was upregulated and SLUG was down regulated in SGECs from pSS versus controls. MMP24 and ZEB2 were higher in SGECs from pSS with a focus score ≥1 versus <1. Lastly, SGECs cocultured with B cells expressed higher levels of COL1A2. These results suggest the existence of a vicious circle. Alteration of SGECs in pSS participates in the establishment of a hyperosmolar microenvironment, which in turn promotes SGECs transcriptomic modifications. These modifications include extracellular matrix remodeling and promote SG lymphocytic infiltration.


Asunto(s)
Síndrome de Sjögren , Humanos , Síndrome de Sjögren/genética , Glándulas Salivales/patología , Células Epiteliales/metabolismo , Matriz Extracelular
4.
J Immunol ; 205(9): 2351-2361, 2020 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-32989091

RESUMEN

The development of anti-drug Abs in response to biological products (BP) is a major drawback in the treatment of patients. Factors related to the patient, the treatment, and the product can influence BP immunogenicity. Among these factors, BP aggregates have been suggested to promote immunogenicity by acting as danger signals recognized by dendritic cells (DC) facilitating the establishment of an anti-BP CD4 T cell-dependent adaptive immune response leading to anti-drug Abs production. To date, little is known on the mechanism supporting the effect of aggregates on DCs and consequently on the T cell response. The aim of this work was to identify key signaling pathways involved in BP aggregate DC activation and T cell response. We generated aggregates by submitting infliximab (IFX), an immunogenic anti-TNF-α chimeric Ab, to heat stress. Our results showed that IFX aggregates were able to induce human monocyte-derived DC (moDC) maturation in a concentration-dependent manner. Aggregate-treated moDCs enhanced allogeneic T cell proliferation and IL-5, IL-9, and IL-13 production compared with native Ab-treated moDCs. We then investigated the implication of FcγRIIa and spleen tyrosine kinase (Syk) in DC activation and showed that they were both strongly implicated in moDC maturation induced by IFX aggregates. Indeed, we found that neutralization of FcγRIIa inhibited DC activation, and consequently, Syk inhibition led to a decrease in T cell proliferation and cytokine production in response to IFX aggregates. Taken together, our results bring new insight, to our knowledge, on how protein aggregates could induce DC and T cell activation via the FcγRIIa-Syk signaling pathway.


Asunto(s)
Células Dendríticas/inmunología , Infliximab/inmunología , Activación de Linfocitos/inmunología , Receptores de IgG/inmunología , Quinasa Syk/inmunología , Linfocitos T/inmunología , Proliferación Celular/fisiología , Células Cultivadas , Humanos , Monocitos/inmunología , Transducción de Señal/inmunología , Factor de Necrosis Tumoral alfa/inmunología
5.
J Immunol ; 205(3): 720-730, 2020 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-32601099

RESUMEN

Oropharyngeal candidiasis (OPC) is an opportunistic infection of the oral mucosa caused by the commensal fungus Candida albicans IL-17R signaling is essential to prevent OPC in mice and humans, but the individual roles of its ligands, IL-17A, IL-17F, and IL-17AF, are less clear. A homozygous IL-17F deficiency in mice does not cause OPC susceptibility, whereas mice lacking IL-17A are moderately susceptible. In humans, a rare heterozygous mutation in IL-17F (IL-17F.S65L) was identified that causes chronic mucocutaneous candidiasis, suggesting the existence of essential antifungal pathways mediated by IL-17F and/or IL-17AF. To investigate the role of IL-17F and IL-17AF in more detail, we exploited this "experiment of nature" by creating a mouse line bearing the homologous mutation in IL-17F (Ser65Leu) by CRISPR/Cas9. Unlike Il17f-/- mice that are resistant to OPC, Il17fS65L/S65L mice showed increased oral fungal burdens similar to Il17a -/- mice. In contrast to humans, however, disease was only evident in homozygous, not heterozygous, mutant mice. The mutation was linked to modestly impaired CXC chemokine expression and neutrophil recruitment to the infected tongue but not to alterations in oral antimicrobial peptide expression. These findings suggest mechanisms by which the enigmatic cytokine IL-17F contributes to host defense against fungi. Moreover, because these mice do not phenocopy Il17f-/- mice, they may provide a valuable tool to interrogate IL-17F and IL-17AF function in vivo in other settings.


Asunto(s)
Candida albicans/inmunología , Candidiasis/inmunología , Interleucina-17/inmunología , Enfermedades de la Boca/inmunología , Animales , Candida albicans/genética , Candidiasis/genética , Candidiasis/patología , Técnicas de Sustitución del Gen , Interleucina-17/genética , Ratones , Ratones Transgénicos , Enfermedades de la Boca/genética , Enfermedades de la Boca/microbiología , Enfermedades de la Boca/patología , Mutación Missense
6.
Eur J Immunol ; 54(2): e2350789, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37846855
9.
Clin Exp Allergy ; 49(5): 636-643, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30657219

RESUMEN

BACKGROUND: Beta-lactams allergy is the most commonly reported drug allergy and constitutes an important health problem. We previously showed the pre-existence of a naïve CD4+ T cell repertoire for benzylpenicillin (BP) coupled to human serum albumin (HSA) but little is known about the naïve CD8+ T cell repertoire specific for BP. OBJECTIVE: The purpose of this work was to identify naïve CD8+ T cells specific for BP and to explore mechanisms dictating their activation. METHODS: Co-cultures were established with naïve CD8+ T cells and autologous dendritic cells (DCs) loaded with HSA-BP or free BP. T cells were restimulated once a week with autologous DCs loaded with HSA-BP or BP. The specific CD8+ T cell response was measured using an IFN-γ ELISpot assay. RESULTS: When using free BP, we were able to detect a naïve CD8+ T cell repertoire for BP in the 6 out of 7 tested healthy donors. However, our results showed that HSA-BP was recognized by naïve CD8+ T cells in only one donor out of five tested healthy donors. Using free BP, we evidenced its binding to cellular proteins in DCs that was concentration dependent and was correlated with BP-specific CD8+ T cell activation. Moreover, the BP-specific CD8+ cell response was MHC class I-dependent and required intracellular processing and proteasome activity. CONCLUSION AND CLINICAL RELEVANCE: This work showed the existence of a naïve CD8+ T cell repertoire for BP when DCs were treated with free BP suggesting that patients could be immunized by haptenated peptides from cellular proteins generated in antigen-presenting cells.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Susceptibilidad a Enfermedades , Hipersensibilidad a las Drogas/inmunología , Penicilina G/efectos adversos , Linfocitos T CD8-positivos/metabolismo , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Susceptibilidad a Enfermedades/inmunología , Hipersensibilidad a las Drogas/diagnóstico , Ensayo de Immunospot Ligado a Enzimas , Epítopos de Linfocito T/inmunología , Haptenos , Antígenos de Histocompatibilidad Clase I/inmunología , Humanos , Activación de Linfocitos/inmunología , Recuento de Linfocitos , Complejo de la Endopetidasa Proteasomal/metabolismo
10.
Arch Toxicol ; 93(4): 941-951, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30806763

RESUMEN

According to the current scientific consensus, one in vitro test is insufficient to cover the key events (KE) defined by the adverse outcome pathway (AOP) for skin sensitization. To address this issue we combined different end points in the same cell line to cover all KEs defined by the skin sensitization AOP. Since dendritic cells (DC) play a key role in the sensitization phase leading to the development of allergic contact dermatitis (ACD), we used THP-1 cells as a surrogate for DC. We measured ROS production and GSH depletion for KE1 (binding to proteins), Nrf2 activation pathway and gene expressions for KE2 (keratinocyte response), phenotype modifications using cell-surface markers and cytokine production for KE3 (DC activation), and T-cell proliferation for KE4 (T-cell activation). These measurements were performed using the THP-1 cell line and an original THP-1/T-cell co-culture system following exposure to a variety of chemicals, including irritant, non-sensitizers, and chemicals sensitizers (pro/prehaptens). Results showed that treatment with sensitizers such as cinnamaldehyde (100 µM) or methylisothiazolinone (150 µM) was able to trigger the three main key events (KE1, KE2, and KE3) of the sensitization phase of ACD in THP-1 cells. In addition, all sensitizers were able to induce T lymphocyte proliferation (KE4), while non-sensitizers and irritants did not. Our study shows for the first time that addressing the four main KE of skin sensitization AOP in a single cell line is an achievable task.


Asunto(s)
Alternativas a las Pruebas en Animales/métodos , Dermatitis Alérgica por Contacto/etiología , Factor 2 Relacionado con NF-E2/metabolismo , Piel/efectos de los fármacos , Rutas de Resultados Adversos , Técnicas de Cocultivo , Citocinas/metabolismo , Células Dendríticas/efectos de los fármacos , Células Dendríticas/inmunología , Dermatitis Alérgica por Contacto/inmunología , Dermatitis Alérgica por Contacto/metabolismo , Humanos , Queratinocitos/efectos de los fármacos , Queratinocitos/inmunología , Activación de Linfocitos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/inmunología , Especies Reactivas de Oxígeno/metabolismo , Piel/inmunología , Piel/metabolismo , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Células THP-1
11.
Chem Res Toxicol ; 31(12): 1323-1331, 2018 12 17.
Artículo en Inglés | MEDLINE | ID: mdl-30421605

RESUMEN

Allergic contact dermatitis (ACD) is a major cause of occupational skin disease, and nickel is among the most prevalent contact allergens. Dendritic cells (DC) play an important role in ACD and in the type of the ensuing immune response through differential phenotypes and cytokine production. The interleukin (IL)-12 cytokine family is composed of heterodimeric cytokines sharing homology at the subunit, receptors and signaling levels. We previously showed that nickel can upregulate the production of IL-12p40 and IL-23, both known to be pro-inflammatory. In this work, we aimed to extend our knowledge on nickel regulation of the IL-12 cytokine family by focusing on IL-27, a recently identified immunomodulatory cytokine from this family. We showed that nickel induced the production of IL-27 in human monocyte-derived DC (MoDC), regulating IL-22 production by human CD4+ T cells. We also showed that nickel was able to induce the expression of the two subunits of IL-27: il-27p28 and ebi3. Furthermore, we demonstrated that the production of IL-27 was dependent on the TLR4, p38 MAPK, NF-κB, and Jak-STAT signaling. However, IL-27 subunits were differentially regulated by these pathways. Indeed, both subunits were positively regulated by the TLR4 and NF-κB pathways, but only il-27p28 was also dependent on p38 MAPK and Jak-STAT pathways. Our results contribute to a better understanding of nickel-induced ACD by focusing on the IL-12 cytokine family and elucidating the mechanism of IL-27 regulation in human dendritic cells.


Asunto(s)
Células Dendríticas/efectos de los fármacos , Interleucina-27/metabolismo , Níquel/toxicidad , Linfocitos T CD4-Positivos/citología , Linfocitos T CD4-Positivos/inmunología , Células Cultivadas , Células Dendríticas/citología , Células Dendríticas/metabolismo , Dermatitis Alérgica por Contacto/metabolismo , Dermatitis Alérgica por Contacto/patología , Humanos , Interleucinas/metabolismo , Monocitos/citología , FN-kappa B/metabolismo , Níquel/química , Transducción de Señal/efectos de los fármacos , Receptor Toll-Like 4/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Interleucina-22
12.
Toxicol Sci ; 200(1): 11-30, 2024 Jun 26.
Artículo en Inglés | MEDLINE | ID: mdl-38588579

RESUMEN

Drug hypersensitivity reactions (DHRs) are a type of adverse drug reaction that can occur with different classes of drugs and affect multiple organ systems and patient populations. DHRs can be classified as allergic or non-allergic based on the cellular mechanisms involved. Whereas nonallergic reactions rely mainly on the innate immune system, allergic reactions involve the generation of an adaptive immune response. Consequently, drug allergies are DHRs for which an immunological mechanism, with antibody and/or T cell, is demonstrated. Despite decades of research, methods to predict the potential for a new chemical entity to cause DHRs or to correctly attribute DHRs to a specific mechanism and a specific molecule are not well-established. This review will focus on allergic reactions induced by systemically administered low-molecular weight drugs with an emphasis on drug- and patient-specific factors that could influence the development of DHRs. Strategies for predicting and diagnosing DHRs, including potential tools based on the current state of the science, will also be discussed.


Asunto(s)
Hipersensibilidad a las Drogas , Humanos , Hipersensibilidad a las Drogas/diagnóstico , Hipersensibilidad a las Drogas/inmunología
13.
Nat Rev Rheumatol ; 19(8): 486-502, 2023 08.
Artículo en Inglés | MEDLINE | ID: mdl-37311941

RESUMEN

Post-transcriptional regulation is a fundamental process in gene expression that has a role in diverse cellular processes, including immune responses. A core concept underlying post-transcriptional regulation is that protein abundance is not solely determined by transcript abundance. Indeed, transcription and translation are not directly coupled, and intervening steps occur between these processes, including the regulation of mRNA stability, localization and alternative splicing, which can impact protein abundance. These steps are controlled by various post-transcription factors such as RNA-binding proteins and non-coding RNAs, including microRNAs, and aberrant post-transcriptional regulation has been implicated in various pathological conditions. Indeed, studies on the pathogenesis of autoimmune and inflammatory diseases have identified various post-transcription factors as important regulators of immune cell-mediated and target effector cell-mediated pathological conditions. This Review summarizes current knowledge regarding the roles of post-transcriptional checkpoints in autoimmunity, as evidenced by studies in both haematopoietic and non-haematopoietic cells, and discusses the relevance of these findings for developing new anti-inflammatory therapies.


Asunto(s)
Autoinmunidad , MicroARNs , Humanos , Autoinmunidad/genética , Regulación de la Expresión Génica , MicroARNs/genética , Factores de Transcripción/genética , Inmunidad
14.
Heliyon ; 8(12): e11793, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36466570

RESUMEN

Anaerobic digestion is a sustainable organic waste treatment technique with energy recovery via biogas generation. This work presents a novel Aspen Plus ADM1-based flowsheet for this process. Three reactor segments were chosen: stoichiometric for the hydrolysis step, kinetic for acido-aceto-methanogenesis, and equilibrium for hydrogenotrophic methane production. Selected parameters- conversion ratios, kinetic pre-exponent and inhibitor factors- were controlled to best fit model and experimental results. The parity plot fitting had an R2 = 0.999, a slope of 1.0058 and an intercept of -0.8651. Obtained parameter values stressed the importance of inhibitions, and simulation results showcased the bell-shaped curve for acetic and volatile fatty acid reduction. The model was used for a subsequent sensitivity analysis as well as an optimization runs, leading to a 50% higher methane production ratio. The proposed model presents itself as a significant contribution for optimal anaerobic digestion process design.

15.
JCI Insight ; 7(3)2022 02 08.
Artículo en Inglés | MEDLINE | ID: mdl-34914635

RESUMEN

Stromal cells are emerging as key drivers of autoimmunity, partially because they produce inflammatory chemokines that orchestrate inflammation. Chemokine expression is regulated transcriptionally but also through posttranscriptional mechanisms, the specific drivers of which are still incompletely defined. CCL2 (MCP1) is a multifunctional chemokine that drives myeloid cell recruitment. During experimental autoimmune encephalomyelitis (EAE), an IL-17-driven model of multiple sclerosis, CCL2 produced by lymph node (LN) stromal cells was essential for immunopathology. Here, we showed that Ccl2 mRNA upregulation in human stromal fibroblasts in response to IL-17 required the RNA-binding protein IGF-2 mRNA-binding protein 2 (IGF2BP2, IMP2), which is expressed almost exclusively in nonhematopoietic cells. IMP2 binds directly to CCL2 mRNA, markedly extending its transcript half-life, and is thus required for efficient CCL2 secretion. Consistent with this, Imp2-/- mice showed reduced CCL2 production in LNs during EAE, causing impairments in monocyte recruitment and Th17 cell polarization. Imp2-/- mice were fully protected from CNS inflammation. Moreover, deletion of IMP2 after EAE onset was sufficient to mitigate disease severity. These data showed that posttranscriptional control of Ccl2 in stromal cells by IMP2 was required to permit IL-17-driven progression of EAE pathogenesis.


Asunto(s)
Autoinmunidad , Encefalomielitis Autoinmune Experimental/genética , Regulación de la Expresión Génica , Proteínas de Unión al ARN/genética , Células Th17/inmunología , Regulación hacia Arriba , Animales , Células Cultivadas , Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/patología , Femenino , Masculino , Ratones , Ratones Endogámicos C57BL , ARN Mensajero/genética , Proteínas de Unión al ARN/biosíntesis , Células Th17/patología
16.
Front Immunol ; 12: 653102, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34267746

RESUMEN

Allergic reactions to drugs and chemicals are mediated by an adaptive immune response involving specific T cells. During thymic selection, T cells that have not yet encountered their cognate antigen are considered naive T cells. Due to the artificial nature of drug/chemical-T-cell epitopes, it is not clear whether thymic selection of drug/chemical-specific T cells is a common phenomenon or remains limited to few donors or simply does not exist, suggesting T-cell receptor (TCR) cross-reactivity with other antigens. Selection of drug/chemical-specific T cells could be a relatively rare event accounting for the low occurrence of drug allergy. On the other hand, a large T-cell repertoire found in multiple donors would underline the potential of a drug/chemical to be recognized by many donors. Recent observations raise the hypothesis that not only the drug/chemical, but also parts of the haptenated protein or peptides may constitute the important structural determinants for antigen recognition by the TCR. These observations may also suggest that in the case of drug/chemical allergy, the T-cell repertoire results from particular properties of certain TCR to recognize hapten-modified peptides without need for previous thymic selection. The aim of this review is to address the existence and the role of a naive T-cell repertoire in drug and chemical allergy. Understanding this role has the potential to reveal efficient strategies not only for allergy diagnosis but also for prediction of the immunogenic potential of new chemicals.


Asunto(s)
Dermatitis por Contacto/inmunología , Hipersensibilidad a las Drogas/inmunología , Epítopos de Linfocito T/metabolismo , Receptores de Antígenos de Linfocitos T/metabolismo , Linfocitos T/inmunología , Reacciones Cruzadas , Epítopos de Linfocito T/inmunología , Haptenos/inmunología , Haptenos/metabolismo , Humanos , Péptidos/inmunología , Péptidos/metabolismo , Linfocitos T/metabolismo
17.
J Exp Med ; 218(5)2021 05 03.
Artículo en Inglés | MEDLINE | ID: mdl-33822846

RESUMEN

IL-17 was discovered nearly 30 yr ago, but it has only been recently appreciated that a key function of this cytokine is to orchestrate cellular and organismal metabolism. Indeed, metabolic regulation is integrated into both the physiological and the pathogenic aspects of IL-17 responses. Thus, understanding the interplay between IL-17 and downstream metabolic processes could ultimately inform therapeutic opportunities for diseases involving IL-17, including some not traditionally linked to this cytokine pathway. Here, we discuss the emerging pathophysiological roles of IL-17 related to cellular and organismal metabolism, including metabolic regulation of IL-17 signal transduction.


Asunto(s)
Glucosa/metabolismo , Glucólisis/fisiología , Interleucina-17/metabolismo , Transducción de Señal/fisiología , Animales , Proliferación Celular/genética , Proliferación Celular/fisiología , Células Epiteliales/citología , Células Epiteliales/metabolismo , Regulación de la Expresión Génica , Glucólisis/genética , Humanos , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/patología
18.
JCI Insight ; 6(13)2021 07 08.
Artículo en Inglés | MEDLINE | ID: mdl-34236049

RESUMEN

Antibody-mediated glomerulonephritis (AGN) is a clinical manifestation of many autoimmune kidney diseases for which few effective treatments exist. Chronic inflammatory circuits in renal glomerular and tubular cells lead to tissue damage in AGN. These cells are targeted by the cytokine IL-17, which has recently been shown to be a central driver of the pathogenesis of AGN. However, surprisingly little is known about the regulation of pathogenic IL-17 signaling in the kidney. Here, using a well-characterized mouse model of AGN, we show that IL-17 signaling in renal tubular epithelial cells (RTECs) is necessary for AGN development. We also show that Regnase-1, an RNA binding protein with endoribonuclease activity, is a negative regulator of IL-17 signaling in RTECs. Accordingly, mice with a selective Regnase-1 deficiency in RTECs exhibited exacerbated kidney dysfunction in AGN. Mechanistically, Regnase-1 inhibits IL-17-driven expression of the transcription factor IκBξ and, consequently, its downstream gene targets, including Il6 and Lcn2. Moreover, deletion of Regnase-1 in human RTECs reduced inflammatory gene expression in a IκBξ-dependent manner. Overall, these data identify an IL-17-driven inflammatory circuit in RTECs during AGN that is constrained by Regnase-1.


Asunto(s)
Enfermedades Autoinmunes/metabolismo , Glomerulonefritis , Proteínas I-kappa B/metabolismo , Interleucina-17/metabolismo , Túbulos Renales , Proteínas Proto-Oncogénicas/metabolismo , Ribonucleasas , Animales , Células Epiteliales/metabolismo , Glomerulonefritis/inmunología , Glomerulonefritis/fisiopatología , Inmunidad Innata , Inflamación/metabolismo , Túbulos Renales/inmunología , Túbulos Renales/patología , Ratones , Insuficiencia Renal/inmunología , Insuficiencia Renal/metabolismo , Ribonucleasas/deficiencia , Ribonucleasas/inmunología , Transducción de Señal/inmunología
19.
Sci Immunol ; 6(61)2021 07 02.
Artículo en Inglés | MEDLINE | ID: mdl-34215679

RESUMEN

Excessive cytokine activity underlies many autoimmune conditions, particularly through the interleukin-17 (IL-17) and tumor necrosis factor-α (TNFα) signaling axis. Both cytokines activate nuclear factor κB, but appropriate induction of downstream effector genes requires coordinated activation of other transcription factors, notably, CCAAT/enhancer binding proteins (C/EBPs). Here, we demonstrate the unexpected involvement of a posttranscriptional "epitranscriptomic" mRNA modification [N6-methyladenosine (m6A)] in regulating C/EBPß and C/EBPδ in response to IL-17A, as well as IL-17F and TNFα. Prompted by the observation that C/EBPß/δ-encoding transcripts contain m6A consensus sites, we show that Cebpd and Cebpb mRNAs are subject to m6A modification. Induction of C/EBPs is enhanced by an m6A methylase "writer" and suppressed by a demethylase "eraser." The only m6A "reader" found to be involved in this pathway was IGF2BP2 (IMP2), and IMP2 occupancy of Cebpd and Cebpb mRNA was enhanced by m6A modification. IMP2 facilitated IL-17-mediated Cebpd mRNA stabilization and promoted translation of C/EBPß/δ in response to IL-17A, IL-17F, and TNFα. RNA sequencing revealed transcriptome-wide IL-17-induced transcripts that are IMP2 influenced, and RNA immunoprecipitation sequencing identified the subset of mRNAs that are directly occupied by IMP2, which included Cebpb and Cebpd Lipocalin-2 (Lcn2), a hallmark of autoimmune kidney injury, was strongly dependent on IL-17, IMP2, and C/EBPß/δ. Imp2-/- mice were resistant to autoantibody-induced glomerulonephritis (AGN), showing impaired renal expression of C/EBPs and Lcn2 Moreover, IMP2 deletion initiated only after AGN onset ameliorated disease. Thus, posttranscriptional regulation of C/EBPs through m6A/IMP2 represents a previously unidentified paradigm of cytokine-driven autoimmune inflammation.


Asunto(s)
Adenosina/análogos & derivados , Proteínas Potenciadoras de Unión a CCAAT/inmunología , Interleucina-17/inmunología , Proteínas de Unión al ARN/inmunología , Factor de Necrosis Tumoral alfa/inmunología , Adenosina/inmunología , Animales , Autoinmunidad/inmunología , Proteínas Potenciadoras de Unión a CCAAT/genética , Línea Celular , Femenino , Humanos , Inflamación/inmunología , Interleucina-17/genética , Masculino , Ratones Endogámicos C57BL , Ratones Noqueados , Proteínas de Unión al ARN/genética
20.
Front Immunol ; 10: 1331, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31249573

RESUMEN

Allergic contact dermatitis caused by contact sensitizers is a T-cell-mediated inflammatory skin disease. The most prevalent contact allergens is nickel. Whereas, memory T cells from nickel-allergic patients are well-characterized, little is known concerning nickel-specific naïve T-cell repertoire. The purpose of this study was to identify and quantify naïve CD4+ and CD8+ T cells recognizing nickel in the general population. Using a T-cell priming in vitro assay based on autologous co-cultures between naïve T cells and dendritic cells loaded with nickel, we were able to detect a naïve CD4+ and CD8+ T-cell repertoire for nickel in 10/11 and 7/8 of the tested donors. We calculated a mean frequency of 0.49 nickel-specific naïve CD4+ T cells and 0.37 nickel-specific naïve CD8+ T cells per million of circulating naïve T cells. The activation of these specific T cells requires MHC molecules and alongside IFN-γ production, some nickel-specific T-cells were able to produce granzyme-B. Interestingly, nickel-specific naïve CD4+ and CD8+ T cells showed a low rate of cross-reactivity with cobalt, another metallic hapten, frequently mixed with nickel in many alloys. Moreover, naïve CD4+ T cells showed a polyclonal TCRß composition and the presence of highly expanded clones with an enrichment and/or preferentially expansion of some TRBV genes that was donor and T-cell specific. Our results contribute to a better understanding of the mechanism of immunization to nickel and propose the T-cell priming assay as a useful tool to identify antigen-specific naïve T cells.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Dermatitis Alérgica por Contacto/inmunología , Circulación Sanguínea , Células Cultivadas , Células Clonales , Ensayo de Immunospot Ligado a Enzimas , Genes Codificadores de la Cadena beta de los Receptores de Linfocito T/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Inmunofenotipificación , Interferón gamma/metabolismo , Activación de Linfocitos , Níquel , Especificidad del Receptor de Antígeno de Linfocitos T
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA